Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more
Microbio Co Ltd (4128) - Total Liabilities
Latest total liabilities as of September 2025: NT$2.04 Billion TWD
Based on the latest financial reports, Microbio Co Ltd (4128) has total liabilities worth NT$2.04 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Microbio Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Microbio Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Microbio Co Ltd Competitors by Total Liabilities
The table below lists competitors of Microbio Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Weihong Electronic Technology Co Ltd
SHE:300508
|
China | CN¥185.31 Million |
|
Odfjell SE
OL:ODF
|
Norway | Nkr1.04 Billion |
|
XinJiang GuoTong Pipeline Co Ltd
SHE:002205
|
China | CN¥3.52 Billion |
|
Avia Avian PT Tbk
JK:AVIA
|
Indonesia | Rp1.33 Trillion |
|
Senvest Capital Inc
PINK:SVCTF
|
USA | $4.19 Billion |
|
MCNEX Co. Ltd
KQ:097520
|
Korea | ₩221.01 Billion |
|
Sumber Tani Agung Resources Tbk PT
JK:STAA
|
Indonesia | Rp2.82 Trillion |
|
Funding Circle Holdings plc
PINK:FDCHF
|
USA | $307.45 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Microbio Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Microbio Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Microbio Co Ltd (2006–2024)
The table below shows the annual total liabilities of Microbio Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$2.06 Billion | +66.68% |
| 2023-12-31 | NT$1.23 Billion | +14.07% |
| 2022-12-31 | NT$1.08 Billion | -7.73% |
| 2021-12-31 | NT$1.17 Billion | +9.28% |
| 2020-12-31 | NT$1.07 Billion | +6.37% |
| 2019-12-31 | NT$1.01 Billion | +81.80% |
| 2018-12-31 | NT$555.11 Million | -35.41% |
| 2017-12-31 | NT$859.50 Million | +1.82% |
| 2016-12-31 | NT$844.17 Million | -5.09% |
| 2015-12-31 | NT$889.40 Million | +37.71% |
| 2014-12-31 | NT$645.86 Million | -22.56% |
| 2013-12-31 | NT$834.06 Million | -11.50% |
| 2012-12-31 | NT$942.47 Million | +128.87% |
| 2011-12-31 | NT$411.80 Million | -16.71% |
| 2010-12-31 | NT$494.42 Million | -22.59% |
| 2009-12-31 | NT$638.68 Million | +34.81% |
| 2008-12-31 | NT$473.77 Million | +6.83% |
| 2007-12-31 | NT$443.47 Million | +83.42% |
| 2006-12-31 | NT$241.78 Million | -- |